Platinum Peptides Research Use Policy

This policy governs how all materials supplied by Platinum Peptides may be used, who may purchase them, and what uses are expressly prohibited. Accessing this website or placing an order constitutes acceptance of this policy in full.

Not for human use. Research purposes only.

1. PURPOSE OF THIS POLICY

This Research Use Policy exists to clearly define the scope, limitations, and conditions of supply for all synthetic peptide materials available through Platinum Peptides. It is designed to ensure that every buyer, every order, and every material dispatched by Platinum Peptides falls within a legitimate, non-clinical research use framework — consistent with Australian regulatory standards and international research supply best practice.

This policy applies to all visitors, registered account holders, and buyers who interact with the Platinum Peptides website or place orders through any channel.

2. REGULATORY BACKGROUND | AUSTRALIA 2026

Synthetic peptide materials occupy a defined and closely monitored regulatory space in Australia. The Therapeutic Goods Act 1989 (Cth) governs the regulation of therapeutic goods — products that are represented as, or are likely to be taken to be, intended for therapeutic use in humans. Products meeting the definition of therapeutic goods must be included on the Australian Register of Therapeutic Goods (ARTG) before they can be lawfully supplied.

In April and June 2026, the Therapeutic Goods Administration issued formal public warnings and confirmed that unapproved peptide products have become a designated compliance enforcement priority for 2026 and 2027. The TGA has specifically noted the rise in the promotion and supply of peptide products with claims relating to weight loss, anti-ageing, muscle growth, cognitive enhancement, and athletic performance — none of which have been assessed or approved by the TGA. Enforcement actions, including seizures, charges, and prosecutions, have been undertaken across Australia.

Platinum Peptides does not supply therapeutic goods. All materials are supplied exclusively as non-clinical laboratory research materials and are not positioned, promoted, labelled, or supplied as therapeutic goods in any form. Nothing on this website constitutes a therapeutic claim.

3. NATURE OF MATERIALS SUPPLIED

All materials available through Platinum Peptides are:

Synthetic peptide materials produced for non-clinical laboratory research use
Analytically characterised and batch-documented research-grade materials
Not registered on the ARTG
Not approved by the TGA for therapeutic, clinical, diagnostic, or human use
Not represented as medicines, supplements, biologicals, or medical devices
Not intended for or suitable for administration to humans or animals outside a properly governed research context

4. PERMITTED USES

Materials supplied by Platinum Peptides are intended exclusively for the following uses:

In-Vitro Research
Laboratory-based investigation conducted entirely outside a living organism — including cell culture studies, assay development, biochemical analysis, and molecular pathway research.

Pre-Clinical Research
Structured non-clinical investigation conducted under appropriate institutional ethics and governance oversight, where materials are used within a formally approved research program.

Analytical and Reference Use
Use of materials as analytical reference compounds within a laboratory setting for characterisation, method development, or quality research purposes.

Non-Clinical Industrial Research and Development
Use within a registered commercial entity conducting documented non-clinical research and development activities.

5. PROHIBITED USES

The following uses are expressly prohibited under this policy. Platinum Peptides will not knowingly supply materials for any of the following purposes, and any order identified as being for a prohibited use will be declined or cancelled.

Human Administration

Self-administration in any form
Administration to any other person
Use as an injectable, oral, topical, or any other form of human-use product

Consumer and Personal Use

Personal health management of any kind
Bodybuilding, physique enhancement, or strength training
Athletic or performance enhancement
Weight loss, metabolic self-treatment, or appetite management
Cosmetic, anti-ageing, skin, tanning, or aesthetic application
Sexual wellness, libido, erectile function, or reproductive management
Cognitive enhancement or nootropic personal use

Clinical and Therapeutic Application

Use in clinical treatment of any disease or medical condition
Prescribing, dispensing, or administering to patients
Use within a clinical trial unless properly registered and governed under the TGA Clinical Trial framework

Commercial Misuse

Resale of materials to consumer markets or personal-use buyers
Repackaging materials for consumer sale
Promotion of materials with therapeutic, health outcome, or human-use claims

6. BUYER RESPONSIBILITIES

Every buyer who purchases from Platinum Peptides accepts the following responsibilities:

To use materials only for the permitted research purposes set out in Section 4 of this policy
To store and handle materials in compliance with applicable laboratory safety standards and institutional requirements
To comply with all applicable Australian laws and regulations relevant to the possession, use, and disposal of research materials
To accurately represent their identity, institutional affiliation, and research purpose when placing an order
To immediately notify Platinum Peptides if the intended use of materials changes following purchase
To not transfer, resell, or redistribute materials to any third party for consumer or personal use

7. NO THERAPEUTIC REPRESENTATION

Platinum Peptides does not make any representation, express or implied, that any material supplied is:

Safe or suitable for human use
Effective for any therapeutic, health, cosmetic, or performance purpose
Approved, assessed, or endorsed by the TGA, the TGA’s equivalent in any jurisdiction, or any other regulatory authority for human use
Equivalent or comparable to any registered medicine, therapeutic product, or approved drug

No content published on the Platinum Peptides website constitutes medical advice, clinical guidance, prescribing information, dosage guidance, or any form of health recommendation. Buyers must not interpret product descriptions, batch documentation, or purity specifications as claims of safety or efficacy for human use.

8. DOCUMENTATION PURPOSE

Analytical documentation provided with each batch, including Certificates of Analysis, HP LC purity data, and mass spectrometry confirmation, is provided exclusively to support research procurement traceability and material specification verification. This documentation confirms the analytical characteristics of research materials. It does not constitute proof of safety, approval, or suitability for human administration.

9. PLATINUM PEPTIDES' RIGHT TO REFUSE SUPPLY

Platinum Peptides reserves the right at its absolute discretion to:

Decline any order where buyer’s eligibility cannot be verified
Cancel any order where the stated or apparent use does not align with permitted research purposes
Suspend or close accounts where policy breaches are identified
Require additional information from any buyer before processing an order
Report suspected unlawful activity to the relevant Australian authorities where required

10. ACKNOWLEDGEMENT AND ACCEPTANCE

By accessing the Platinum Peptides website, browsing materials, placing an order, or using this site in any way, you confirm that:

You have read and understood this Research Use Policy
You meet the buyer eligibility criteria set out at /research-buyer-verification/
Your intended use of materials is limited strictly to permitted non-clinical laboratory research
You are not purchasing materials for personal use, human administration, or any prohibited use
You accept full responsibility for compliance with all applicable laws in your jurisdiction

All buyers must additionally complete and submit the mandatory buyer declaration at checkout before any order can be processed.

11. POLICY UPDATES

This policy is reviewed and updated regularly in line with changes to Australian regulatory guidance, TGA compliance priorities, and applicable legislation. The current version of this policy applies to all orders placed from the date shown below.

Last Reviewed: June 2026

REGULATORY COMPLIANCE NOTICE — PLATINUM PEPTIDES AUSTRALIA

All materials listed on this website are supplied exclusively for laboratory research purposes. They are not therapeutic goods, are not approved for human use, and are not intended for personal, clinical, or consumer use of any kind. Platinum Peptides complies with applicable Australian regulations governing the supply of research materials, including the Therapeutic Goods Act 1989 (Cth). By accessing this site, you confirm that you are a qualified research buyer.